Navigation Links
China-Biotics, Inc. Files Application for Nasdaq Listing
Date:7/18/2008

SHANGHAI, China, July 18 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced it has applied for listing approval on the Nasdaq Global Market ("Nasdaq").

"This is an important milestone for China-Biotics, and we are committed to working with Nasdaq to fulfill all of its listing requirements," said Mr. Jinan Song, China-Biotics' Chairman and Chief Executive Officer. "Nasdaq is a prestigious senior exchange that is well suited for high-technology and high-growth companies such as China-Biotics that meet its stringent listing requirements. Nasdaq's complement of small-cap, rapidly growing companies will increase our visibility among investors who follow companies like ours, improving trading volume and liquidity. This should, in turn, attract new investors to our Company."

China-Biotics believes it satisfies all of the listing qualifications associated with this application. The application is subject to review by Nasdaq's Listing Qualifications Department for compliance with all Nasdaq Global Market requirements. The Company's common stock will continue to trade on the OTC Bulletin Board under its current symbol, CHBT, until the Company is notified of its acceptance. We hope to receive approval to list on Nasdaq within two to three months.

About China-Biotics, Inc.

Headquartered in Shanghai, China-Biotics, Inc. ("China-Biotics", "the Company") was founded in 1999 and is one of China's largest suppliers of probiotics. Probiotics are beneficial live bacteria used as dietary supplements and food additives to improve intestinal health and digestion. The Company's product portfolio contains live microbials made with proprietary technology. Currently, these products are sold over-the-counter under the "Shining" brand through large distributors to more than 1,000 pharmacies and 100 supermarkets in Shanghai, Jiangsu and Zhejiang. Shining is one of the most recognized brands in Shanghai. China-Biotics plans to expand its retail sales to other major cities in China and is launching 300 Shining brand logistic centers in these cities. There is a significant demand for probiotics for use in the bulk additive market, which is currently met by imports. China-Biotics is building a new plant that will increase its production capacity manyfold to capture this market. For more information, please visit http://www.chn-biotics.com .

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors include, but are not limited to, the Company's ability to market existing and new products, ability to access capital for expansion, and changes from anticipated levels of sales, future national or regional economic and competitive conditions, changes in relationships with customers, dependence on its flagship product profits and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please contact:

CCG Investor Relations

Crocker Coulson, President

Tel: +1-646-213-1915 (New York)

Email: crocker.coulson@ccgir.com

Web: http://www.ccgir.com


'/>"/>
SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008
2. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results
3. China-Biotics, Inc. to Present at Chinas 3rd Annual Food Safety Technology Forum 2008
4. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
5. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
6. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
7. China-Biotics, Inc. Completes Foundation for Its New Plant
8. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
9. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
10. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
11. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Cleveleys, UK (PRWEB) , ... ... ... results presented by surgeons at the 2016 annual meeting of the North ... beneficial clinical outcomes, for patients in the majority of cases, when PEEK-OPTIMA™ ...
(Date:1/17/2017)... 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... a global Phase 2b induction study in ulcerative ... alpha4beta7 integrin. The aim of this randomized, double-blind, ... safety/tolerability and efficacy of PTG-100 in approximately 240 ... active disease. "We are very ...
(Date:1/16/2017)... 16, 2017  Eurofins Genomics today announced the expansion ... customers to receive their primers in a shorter turnaround ... quality found with other providers. Express oligos are available ... at no additional fee. Researchers use ... including DNA sequencing, genotyping, site-directed mutagenesis, and cloning. Often, ...
(Date:1/13/2017)... ... January 13, 2017 , ... Two ... organic compound called fulvic acid that farms, greenhouses and hydroponics operations use to ... are among the fastest growing segments of customers using this high grade fulvic ...
Breaking Biology Technology:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell , ... technology, and STMicroelectronics (NYSE: STM), a global ... electronics applications, announced today the launch of a ... biometric wearables that includes ST,s compact SensorTile ... Benchmark™ biometric sensor system. Together, SensorTile and ...
(Date:12/15/2016)... , December 15, 2016 Arvato ... an agreement with NuData Security, an award-winning international ... will enable clients to focus on good customer experience, balancing ... regulation. ... In order to provide a one-stop fraud prevention suite, Arvato ...
(Date:12/15/2016)... 2016 "Increase in mobile transactions is driving ... biometrics market is expected to grow from USD 4.03 ... at a CAGR of 29.3% between 2016 and 2022. ... growing demand for smart devices, government initiatives, and increasing ... component is expected to grow at a high rate ...
Breaking Biology News(10 mins):